派林生物 (000403.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(派林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 435,640,719.292,328,723,280.441,374,813,312.16709,071,800.34260,860,262.392,405,188,425.371,493,472,266.77991,052,056.37500,420,632.99
 营业利润(元) 149,114,003.51695,187,632.41372,635,563.90161,363,516.7663,173,481.12663,429,496.09398,213,050.72253,314,042.20120,103,775.12
 利润总额(元) 140,949,650.07688,108,822.60370,068,990.92159,329,317.4162,916,890.35660,392,139.13396,535,344.30251,971,891.63118,976,539.75
 净利润(元) 121,869,775.56611,472,470.99325,813,319.79143,000,998.9456,218,316.92587,690,140.23350,545,112.47221,591,411.72106,003,691.20
 归属于母公司股东的净利润(元) 121,948,626.85612,111,043.76326,195,419.81143,137,171.5156,376,087.53587,131,491.86349,539,454.75221,005,894.53105,604,403.84
盈利能力:
 销售毛利率(%) 51.4251.4850.0548.7548.4152.1349.6747.3745.61
 销售净利率(%) 27.9726.2623.7020.1721.5524.4323.4722.3621.18
 净资产收益率(%) 1.688.564.752.130.84----
 总资产报酬率ROA(%) 1.537.594.141.670.65----
 投入资本回报率ROIC(%) 1.528.084.411.950.788.605.233.321.61
营运能力:
 存货周转率(次) 0.221.470.770.450.18----
 应收账款周转率(次) 0.923.282.701.470.51----
 总资产周转率(次) 0.050.280.170.090.03----
偿债能力:
 资产负债率(%) 13.4614.0013.5314.2812.6314.0512.4912.6911.02
 股东权益比率(%) 86.6286.0786.5585.8087.4586.0387.4887.2988.96
 已获利息倍数(倍) -9.47-10.95-7.64-4.42-3.61-10.94-9.20-8.84-8.42
 流动比率 4.013.723.643.333.743.183.413.273.77
 速动比率 2.652.692.452.302.652.462.342.352.69
发展能力:
 营业收入增长率(%) 67.00-3.18-7.95-28.45-47.8721.9811.2725.3575.67
 营业利润增长率(%) 136.044.79-6.42-36.30-47.4044.0913.3324.8686.17
 税后利润增长率(%) 116.314.25-6.68-35.23-46.6250.1415.0225.6087.24
 净资产增长率(%) 8.958.178.066.637.708.576.157.058.27
 总资产增长率(%) 9.998.129.238.499.5612.629.9910.394.40

前瞻产业研究院